ArticleBMC cancer2013

Microspheres targeted with a mesothelin antibody and loaded with doxorubicin reduce tumor volume of human mesotheliomas in xenografts.

Sherrill L Macura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.